Quanterix (NASDAQ:QTRX) Issues Earnings Results

Quanterix (NASDAQ:QTRX) announced its quarterly earnings results on Monday. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Stock Performance

Shares of NASDAQ QTRX traded up $0.22 during mid-day trading on Monday, hitting $7.28. 564,067 shares of the stock were exchanged, compared to its average volume of 492,294. The company has a market cap of $280.45 million, a P/E ratio of -6.87 and a beta of 1.33. The stock’s fifty day simple moving average is $8.59 and its two-hundred day simple moving average is $11.01. Quanterix has a twelve month low of $6.80 and a twelve month high of $27.37.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.